At TRB we know the importance of taking care of our athletes’ tendons. Tendinopathy, a common injury among football players, can lead to chronic pain and even career-ending consequences. That’s why we’re excited to announce our presence at the Isokinetic Football Medicine Conference 2023 in London.
At the conference, we’ll join other experts in the field to discuss the latest advancements in football medicine and share our product’s benefits in caring for tendons and tendinopathies. Our product has been specifically designed to help alleviate the pain and discomfort experienced by players suffering from tendinopathy, while also promoting tendon healing and improving tendon function.
We encourage all sports medicine professionals to join us at the conference and contribute to the discussion on how we can improve player health worldwide. By working together, we can ensure that players receive the best possible care and support for their tendons, allowing them to perform at their best on the field. Don’t miss out on this opportunity to network with other like-minded professionals and stay up-to-date on the latest advancements in football medicine. See you there!
We are delighted to announce that we will be participating in the WCO-IOF-ESCEO Barcelona 2023, the world’s leading congress on osteoporosis, osteoarthritis and musculoskeletal diseases. This congress, organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), will take place from May 4 to May 7, 2023 in Barcelona, Spain.
This is a great opportunity for us to showcase our innovative products for osteoarthritis and other musculoskeletal conditions. We will be presenting our latest research, clinical data and solutions at our booth n°28. We invite you to come and visit us and learn more about how we can help you improve your patients’ quality of life.
We look forward to meeting you at WCO-IOF-ESCEO Barcelona 2023 and sharing our passion for musculoskeletal health.
Learn more about our products for osteoarthritis and other musculoskeletal conditions on our swiss website.
We are excited to announce that TRB will be participating in the CPHI North America 2023, the premier event for the US pharma industry. Come and visit us on booth 643 from April 25-27 in Philadelphia, where you can learn more about our cutting-edge APIs, our company and our services. This is a great opportunity to find out how we can support you in reaching your objectives. We look forward to seeing you there!
Learn more about CPHI.
Find out more about TRB
At TRB Chemedica, we are committed to advancing the field of osteoarthritis treatment by researching, developing, manufacturing, and marketing various molecules, such as hyaluronic acid and diacerein, to manage osteoarthritis-induced pain.
As osteoarthritis is one of our areas of focus, we are pleased to announce our sponsorship of this year’s Osteoarthritis Research Society International (OARSI) conference in Denver, which is dedicated to advancing prevention and treatment of osteoarthritis, and thus support their mission.
TRB Thailand has a long and significant history dating back to 1997, when the company first started with only three employees. Today, TRB Thailand employs over 120 people, making it a key subsidiary of the TRB Group.
To celebrate this momentous occasion, our amazing Thai team put together a fantastic party that was attended by over one hundred staff members. Speeches were given by several TRB leaders during the evening, making it a truly special event for all who attended.
World Arthritis Day, referred to as WAD, aims at increasing disease awareness and knowledge on rheumatological conditions around the world. Current estimates list more than 200 rheumatic and musculoskeletal diseases (RMD), but their burden is largely underestimated by the general population. Consequently, a large proportion of patients are either not diagnosed or wait for extended periods of time before consulting their healthcare professionals.
More than 100.000.000 people worldwide suffer from rheumatological symptoms. These symptoms directly impact the quality of life of the patients and their professional activity. The inability to work reduces individuals’ self-esteem and increases their dependence on social assistance, family and friends.
Medical education has for a long time considered RMDs as second priority conditions, which means that symptoms might go unnoticed, misdiagnosed, or mistreated if people don’t have access to rheumatologists, nurses, physical therapists, or other healthcare professionals specifically trained in the field of RMD. As a result, people living with a rheumatic or musculoskeletal disease often have to face their condition alone and are lacking information on their symptoms, diagnosis and treatment options.
World Arthritis Day is intended to raise awareness on the existence and impact of RMD worldwide. This Day is an opportunity for all communities around the world to come together and speak with one voice to bring the much-needed messages to all audiences.
Over the past 20 years, TRB Chemedica has focused its rheumatological activities on osteoarthritis, the most prevalent joint disorder especially in middle-aged and elderly people.
Every year, CPHI brings together over 100,000 pharmaceutical industry professionals from around the world in physical and online workshops for the purpose of networking and identifying business opportunities. This year’s event is expected to be one of the busiest yet with over 39,000 expected participants.
If you are planning to attend, do not miss the opportunity to visit our stand #41F52.
Please contact our team for more information or to schedule a meeting onsite.
We are proud to announce the 20th anniversary of TRB UK! Responsible for marketing our rheumatology and ophthalmology product ranges in the UK and Ireland since 2002, TRB UK is an ISO 9001 certified company, an achievement that demonstrates our commitment to patients and healthcare professionals and our dedication to quality.
We are glad to welcome you at TRB’s Isokinetic Conference Workshop on Saturday June 4, 2022, to discuss the benefits of hyaluronic acid in high impact sports. The workshop will focus on early osteoarthritis in athletes and hyaluronic acid in tendinopathies. Join us in Lyon to learn more about these topics and exchange with our panel of speakers.
Saturday, 4 June 2022, 16:30-18:00, Room Bellecour 3
|16:30-16:35||Introduction||Dr. Kal Parmar|
|16:35-16:50||Hyaluronic acid: unique features and biomedical opportunities||Pauline Cipriano-Bonvin, PhD|
|16:50-16:55||Q&As||Pauline Cipriano-Bonvin, PhD|
|16:55-17:15||Early osteoarthritis in athletes: causes and management||Prof. Waqar Bhatti|
|17:15-17:25||Q&As||Prof. Waqar Bhatti|
|17:25-17:45||Hyaluronic acid in tendinopathies||Dr. Jörg Dünkel|
|17:45-17:55||Q&As||Dr. Jörg Dünkel|
|17:55-18:00||Conclusion and closing remarks||Dr. Kal Parmar|
We invite you to come visit our booth n°29/30 in Lyon at the Isokinetic Conference from 4th-6th June 2022. From relieving tendinopathy to accelerating post-arthroscopy recovery, we will be happy to share our expertise in relevant and exciting fields at this landmark event in Football Medicine & Orthopaedic Rehabilitation.
You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.
As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.CONTINUE